Canada Pension Plan Investment Board Sells 148,339 Shares of Thermo Fisher Scientific Inc. $TMO

Key Points

• The Canada Pension Plan Investment Board reduced its stake in Thermo Fisher Scientific by 24.1%, now owning approximately 0.12% of the company, valued at $232.2 million.
• Thermo Fisher Scientific reported $5.36 earnings per share (EPS) for the last quarter, exceeding analysts' expectations and marking a 2.9% revenue increase year-over-year.
• The company has announced a quarterly dividend of $0.43 per share, with an ex-dividend date on September 15th, representing an annual yield of 0.4%.

Canada Pension Plan Investment Board lowered its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 24.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 466,622 shares of the medical research company's stock after selling 148,339 shares during the quarter. Canada Pension Plan Investment Board owned about 0.12% of Thermo Fisher Scientific worth $232,191,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. GAMMA Investing LLC lifted its stake in Thermo Fisher Scientific by 60,610.9% during the 1st quarter. GAMMA Investing LLC now owns 2,419,331 shares of the medical research company's stock valued at $1,203,859,000 after acquiring an additional 2,415,346 shares in the last quarter. Nuveen LLC bought a new position in Thermo Fisher Scientific during the 1st quarter valued at $532,360,000. Farallon Capital Management LLC lifted its stake in Thermo Fisher Scientific by 73.8% during the 4th quarter. Farallon Capital Management LLC now owns 1,233,256 shares of the medical research company's stock valued at $641,577,000 after acquiring an additional 523,800 shares in the last quarter. Sarasin & Partners LLP bought a new position in Thermo Fisher Scientific during the 1st quarter valued at $242,991,000. Finally, Two Sigma Advisers LP lifted its stake in Thermo Fisher Scientific by 81.6% during the 4th quarter. Two Sigma Advisers LP now owns 933,200 shares of the medical research company's stock valued at $485,479,000 after acquiring an additional 419,200 shares in the last quarter. Institutional investors and hedge funds own 89.23% of the company's stock.

Thermo Fisher Scientific Stock Performance

Thermo Fisher Scientific stock traded up $3.31 during midday trading on Monday, reaching $493.05. The stock had a trading volume of 1,228,194 shares, compared to its average volume of 1,834,312. Thermo Fisher Scientific Inc. has a 12 month low of $385.46 and a 12 month high of $627.88. The firm's 50-day moving average price is $452.50 and its 200 day moving average price is $453.78. The firm has a market capitalization of $186.18 billion, a PE ratio of 28.52, a P/E/G ratio of 2.63 and a beta of 0.75. The company has a quick ratio of 1.50, a current ratio of 1.93 and a debt-to-equity ratio of 0.65.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.22 by $0.14. Thermo Fisher Scientific had a return on equity of 16.82% and a net margin of 15.24%.The business had revenue of $10.86 billion for the quarter, compared to analysts' expectations of $10.68 billion. During the same period in the previous year, the business posted $5.37 EPS. The firm's quarterly revenue was up 2.9% compared to the same quarter last year. Thermo Fisher Scientific has set its Q3 2025 guidance at 5.460-5.510 EPS. FY 2025 guidance at 22.220-22.840 EPS. As a group, research analysts predict that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.

Thermo Fisher Scientific Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Monday, September 15th will be issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Monday, September 15th. Thermo Fisher Scientific's payout ratio is presently 9.95%.

Wall Street Analysts Forecast Growth

TMO has been the topic of several recent analyst reports. William Blair started coverage on Thermo Fisher Scientific in a research note on Monday, August 18th. They set an "outperform" rating on the stock. Evercore ISI lowered their target price on Thermo Fisher Scientific from $500.00 to $480.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. HSBC reiterated a "hold" rating and set a $510.00 target price on shares of Thermo Fisher Scientific in a research note on Thursday, July 24th. Raymond James Financial reiterated an "outperform" rating and set a $535.00 target price (up from $525.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 24th. Finally, Scotiabank upgraded Thermo Fisher Scientific from a "sector perform" rating to a "sector outperform" rating and set a $590.00 target price on the stock in a research note on Friday, July 11th. Sixteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $593.00.

Insider Transactions at Thermo Fisher Scientific

In other Thermo Fisher Scientific news, EVP Gianluca Pettiti sold 400 shares of Thermo Fisher Scientific stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $479.98, for a total transaction of $191,992.00. Following the completion of the transaction, the executive vice president owned 22,367 shares of the company's stock, valued at $10,735,712.66. The trade was a 1.76% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Marc N. Casper sold 10,000 shares of Thermo Fisher Scientific stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $500.96, for a total value of $5,009,600.00. Following the transaction, the chief executive officer directly owned 115,174 shares of the company's stock, valued at $57,697,567.04. The trade was a 7.99% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 28,896 shares of company stock valued at $13,603,438 in the last ninety days. Insiders own 0.33% of the company's stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.